MENU
AVIR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Atea Pharmaceuticals (AVIR) Ownership - Who owns Atea Pharmaceuticals?

Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
225 Franklin Street
Phone
+1 857 284-8891
Employees
55
Web
https://www.ateapharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
347.72M
P/E Ratio
N/A
Total Cash
256.01M
Projected Growth
N/A
Total Debt
634K
Revenue
N/A
Risk (Beta)
-0.22
Dividend Yield
N/A
Total Cash/Share
3.20
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
AVIR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of vaccines

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
225 Franklin Street
Phone
+1 857 284-8891
Employees
55
Web
https://www.ateapharma.com